drugset / Trial / NCT05408247
A Randomised Controlled Trial of N-acetylcysteine for the Management of Alcohol Use Disorder
RandomizedParallel-groupQuadruple-blindTreatment
Summary
To explore the effectiveness of n-acetylcysteine in improving treatment outcomes for alcohol use disorder in a double-blind randomised placebo-controlled trial.
Timeline
- Start
- 2023-02-16
- Primary completion
- 2025-11
- Completion
- 2026-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | N-acetylcysteine | Small molecule | 1200 mg | Oral |